Stonepine Capital Management, LLC 13D and 13G filings for Tenax Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-11-13 5:35 pm Unchanged | 2024-09-30 | 13G | Tenax Therapeutics, Inc. TENX | Stonepine Capital Management, LLC | 372,797 9.990% | 0 (Unchanged) | Filing |
2024-08-15 4:19 pm Purchase | 2024-08-06 | 13G | Tenax Therapeutics, Inc. TENX | Stonepine Capital Management, LLC | 372,797 9.990% | 372,797 (New Position) | Filing |